Carl Icahn Goes Activist on Talisman Energy

Carl Icahn, Talisman Energy: In a 13D just filed with the SEC, Carl Icahn has reported a 5.9% stake in Talisman Energy Inc. (USA) (NYSE:TLM). Three of Icahn’s seven largest positions are in energy companies, and the corporate raider lists undervaluation, asset sales, restructuring and Board representation as possible outcomes of his activist stake.

One interesting thing to point out: at the end of last quarter, Icahn’s former right hand man, Keith Meister, was Talisman’s largest shareholder. Meister’s Corvex Capital held a $103.5 million position, roughly one-sixth the size of Icahn’s new stake.

Carl Icahn as viking

In addition to Icahn’s move, there have been many other big-time hedge fund trades in the past week. Here’s a look at the most important.

Bill Ackman reduced his Herbalife short significantly, replacing it with long-term put options.

Dan Loeb ups his activist campaign at Sotheby’s, snatching 9.3% of the company while calling for its CEO to resign.

Activist Barry Rosenstein and Jana Partners disclosed a 13.5% stake in Outerwall (formerly Coinstar).

Billionaire Stephen Mandel now owns 5.3% of Pandora.

Mick McGuire and Marcato Capital reported that they still hold a large stake in Sotheby’s alongside Loeb.

Jeff Ubben and ValueAct, another activist, now own 9.7% of Rockwell Collins; say they’re banking on avionics division.

Richard Perry cuts 9M J.C. Penney shares.

Dmitry Balyasny’s Walter Energy bet shows he doesn’t think coal is dead just yet.

Ken Griffin’s Citadel Advisors reported a new 5.8% stake in Global Brass and Copper Holdings.

Ricky Sandler, Eminence Capital up their Aeropostale position.

Peter Kolchinsky’s biotech fund doubles its Achillion Pharmaceuticals stake.

Andrew Feldstein and Stephen Siderow joined a REIT party at Chatham Lodging Trust.

Recommended Reading:

Now We Know Why Julian Robertson Sold Apple Earlier This Year

Hedge Fund News: Bruce Berkowitz, George Soros & Carl Icahn’s Raider Lifestyle

Activist Lawrence Seidman Ups His Position in OBA Financial

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!